Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Respiri Limited ( (AU:RSH) ) has issued an announcement.
Respiri Limited has announced a webinar scheduled for March 17, 2025, where Managing Director Marjan Mikel will discuss the company’s U.S. growth plans, major deals, and the future of connected care. This event signifies Respiri’s commitment to expanding its presence in the U.S. market, leveraging its advanced healthcare solutions to enhance patient care and reduce healthcare costs. The announcement underscores the company’s strategic focus on integrating their technologies into existing healthcare systems, thereby positioning themselves as a key player in the chronic disease management sector.
More about Respiri Limited
Respiri Limited is a Connected Care Management Company that specializes in remote patient monitoring services, particularly in the USA. The company is a leader in medical devices and MedTech, focusing on chronic disease management through innovative technologies and strategic partnerships. Their flagship product, wheezo®, is an FDA-approved device for detecting wheeze, integrated into remote patient monitoring programs.
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $44.91M
See more insights into RSH stock on TipRanks’ Stock Analysis page.